Good Clinical Practice
Good Clinical Practice (GCP) is the international quality standard for designing, conducting, recording, and reporting clinical trials.
## What Is GCP?
Good Clinical Practice (GCP) is the international ethical and scientific quality standard for the design, conduct, performance, monitoring, auditing, recording, analysis, and reporting of clinical trials. Compliance with GCP provides public assurance that participant rights, safety, and well-being are protected and that trial data are credible. The primary reference document is ICH E6(R2), developed by the International Council for Harmonisation and adopted by regulatory agencies worldwide.
## The 13 Principles of ICH-GCP
The foundational principles include:
1. Clinical trials must be conducted in accordance with the ethical principles of the Declaration of Helsinki
2. Risks to participants must be minimized and reasonable relative to anticipated benefits
3. Participant rights, safety, and well-being take priority over the interests of science and society
4. Available nonclinical and clinical information must support the proposed investigation
5. Trials must be scientifically sound and described in a clear, detailed protocol
6. Trials must be conducted in compliance with the approved protocol
7. Medical care decisions must be made by qualified physicians
8. All individuals involved must be qualified by education, training, and experience
9. Freely given informed consent must be obtained from every participant
10. All trial information must be recorded, handled, and stored to allow accurate reporting and verification
11. Participant confidentiality must be maintained
12. Investigational products must be manufactured, handled, and stored per GMP standards
13. Quality assurance systems must be implemented
## Key Roles and Responsibilities
### Sponsor
Responsible for trial design, regulatory submissions, investigator selection, supply of investigational product, and overall quality oversight. Must ensure monitoring, auditing, and pharmacovigilance systems are in place.
### Investigator
Responsible for participant care, protocol compliance, data accuracy, and adverse event reporting at the study site. Must maintain adequate qualifications and resources to conduct the trial.
### Ethics Committee / IRB
Provides independent review of the protocol, informed consent documents, and investigator qualifications. Has authority to approve, require modifications to, or disapprove the trial.
## Essential Documents
GCP requires a comprehensive set of essential documents maintained before, during, and after the trial. These include the investigator's brochure, signed protocols, IRB approvals, informed consent forms, case report forms, monitoring visit reports, and the clinical study report. These documents enable quality evaluation and reconstruction of trial conduct.
## GCP Inspections
Regulatory agencies (FDA, EMA, PMDA) conduct inspections of trial sites, sponsors, and contract research organizations to verify GCP compliance. Inspection findings range from minor observations to critical findings that can invalidate trial data.
## Key Takeaways
- GCP is the universal quality standard for clinical trials
- Participant safety and data integrity are the two core objectives
- Sponsors, investigators, and ethics committees have distinct responsibilities
- Essential documents must be maintained throughout the trial lifecycle
- Regulatory inspections verify compliance and can invalidate non-compliant data